Dacula, Al-alshrie D.

HRN: 28-47-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/03/2026
02/10/2026
IV
1.5g
Q6h
Pott’s Disease
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines